Based on data generated from prior trials, our vaccine candidates have shown that participants had increased IgA antibodies to SARS-CoV-2, the virus that causes COVID-19, while maintaining ...
The virus takes control of three key host proteins that suppress the activity of the complement system. Researchers at the ...